Biomarker

The use of a noninvasive skin tape strip at age 2 months can identify infants who are at risk for developing food allergy later, according to a study published in The Journal of Allergy and Clinical Immunology.

A Swiss-based medical technology company has announced a partnership with Biogen to advance a digital biomarker platform involved in a planned clinical trial for BIIB122, a novel therapeutic to treat Parkinson’s disease.

In this edition, race identified as risk factor for VTE, FDA approves Rybrevant for treatment of non-small cell lung cancer and more.

The FDA has granted breakthrough device designation to a phospho-tau 217 blood-based biomarker to assist in the diagnosis of Alzheimer’s disease, according to the manufacturer.

Two blood-based biomarkers may help identify patients with cancer who are more likely to experience gastrointestinal symptoms during chemotherapy.

Most oncologists treating non-small cell lung cancer reported more research into immunotherapy treatments, patients with comorbidities and biomarker testing will be vital to improving care, according to results of a nationwide survey.

In this edition, blood test for lung cancer patients who may benefit from further immunotherapy, invasive procedures following lung cancer screenings and more.

Next-generation technologies and diagnostic tests offer the promise of improved cancer care, but they also present challenges related to ensuring widespread access to these innovations.

In this video, Stephen M. Ansell, MD, PhD, discusses research presented at ASH Annual Meeting and Exposition on circulating tumor DNA.

Researchers reported that a universal risk prediction model incorporating traditional risk factors and cardiac biomarkers accurately estimated risk for adults both with and without baseline atherosclerotic CVD.